Transforming growth factor-beta1 upregulation triggers pulmonary artery smooth muscle cell proliferation and apoptosis imbalance in rats with hypoxic pulmonary hypertension via the PTEN/AKT pathways

被引:39
|
作者
Liu, Yun [1 ]
Cao, Yonggang [2 ]
Sun, Shuyang [3 ]
Zhu, Jinquan [1 ]
Gao, Shan [1 ]
Pang, Jie [1 ]
Zhu, Daling [4 ,5 ]
Sun, Zengxian [1 ]
机构
[1] First Peoples Hosp Lianyungang, Dept Pharm, 182 Tongguan North Rd, Lianyungang 222002, Peoples R China
[2] Harbin Med Univ Daqing, Dept Pharmacol, Daqing 163319, Peoples R China
[3] Nanjing Tech Univ, Overseas Educ Coll, 30 Puzhu South Rd, Nanjing 211816, Jiangsu, Peoples R China
[4] Harbin Med Univ Daqing, Coll Pharm, Dept Biopharmaceut Sci, Daqing 163319, Peoples R China
[5] Biopharmaceut Key Lab Heilongjiang Prov, Harbin, Peoples R China
关键词
Pulmonary arterial hypertension; Transforming growth factor-beta1; PTEN/AKT; Proliferation; Apoptosis; FACTOR-BETA; 15-HYDROXYEICOSATETRAENOIC ACID; TUMOR-SUPPRESSOR; RECEPTOR; 15-HETE; 15-LIPOXYGENASE; PHOSPHATASE; MECHANISMS; TGF-BETA-1; PROTECTS;
D O I
10.1016/j.biocel.2016.06.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transforming growth factor-betal (TGF beta 1) and Phosphatase and Tensin homolog deleted on chromosome ten (PTEN) are involved in the regulation of proliferation, differentiation, migration and apoptosis of various cell types. In previous studies, we have shown that TGF beta 1 and PTEN play an important role in the progression of pulmonary vascular remodeling induced by pulmonary artery smooth muscle cells (PASMCs). However, the mechanisms involved in the activation of PASMCs between TGF beta 1 and PTEN pathways remain unknown. We found that pulmonary vascular walls in hypoxic pulmonary arterial hypertension (PAH) rats were thicker than the vessels from normal rats in vivo. Substantially higher levels of TGF beta 1 and significant loss of PTEN expression were observed in the lungs of PAH rats when compared with normoxia. Meanwhile, AU, a downstream proliferative signaling protein of the PTEN antagonist PI3K, was markedly activated in the lungs of PAH rats. In vitro studies using PASMCs showed that TGF beta 1 increased cell proliferation in PTEN-dependent manner. Moreover, we found that TGF beta 1 enhanced cell survival, up-regulated the expression of Bcl-2 and procaspase-3, decreased the number of TUNEL-positive cells and caspase-3 expression in PASMCs under serum-deprived (SD) condition via PI3K/AKT pathway. The results further establish that TGF beta 1 promoted PAH by decreasing PTEN expression and increasing PI3K/AKT activation in the lung. In conclusion, TGF beta 1 mediated PTEN inactivation and resistance to apoptosis seems to be key mediators of lung vascular remodeling associated with PAH. These findings further clarify molecular mechanisms that support targeting PTEN/AKT signaling pathway to attenuate pathogenic derangements in PAH. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:141 / 154
页数:14
相关论文
共 50 条
  • [31] Imatinib in the Presence of Platelet-derived Growth Factor Inhibits Proliferation and Induces Apoptosis in Pulmonary Artery Smooth Muscle Cells from Patients with Idiopathic Pulmonary Arterial Hypertension
    Nakamura, Kazufumi
    Akagi, Satoshi
    Matsubara, Hiromi
    Ogawa, Aiko
    Miura, Aya
    Miura, Daiji
    Nishii, Nobuhiro
    Nagase, Satoshi
    Kohno, Kunihisa
    Morita, Hiroshi
    Kusano, Kengo F.
    Ito, Hiroshi
    CIRCULATION, 2010, 122 (21)
  • [32] Antisense oligodeoxynucleotide for transforming growth factor β1 modulates cell proliferation and apoptosis in vascular smooth muscle cells
    Wang, TT
    Orlov, S
    Tremblay, J
    Hamet, P
    JOURNAL OF HYPERTENSION, 2000, 18 : S148 - S148
  • [33] Transforming growth factor-β1 protects against pulmonary artery endothelial cell apoptosis via ALK5
    Lu, Qing
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2008, 295 (01) : L123 - L133
  • [34] BMPR-II DYSFUNCTION LEADS TO ABNORMAL GROWTH RESPONSES TO TRANSFORMING GROWTH FACTOR BETA IN PULMONARY ARTERY SMOOTH MUSCLE CELLS: ROLE OF UPREGULATION OF NUCLEAR FACTOR KAPPA B SIGNALLING
    Davies, R. J.
    Upton, P. D.
    Long, L.
    Trembath, R.
    Morrell, N. W.
    THORAX, 2008, 63 : A2 - A2
  • [35] Prostaglandin I2 induces apoptosis via upregulation of Fas ligand in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension
    Akagi, Satoshi
    Nakamura, Kazufumi
    Matsubara, Hiromi
    Kusano, Kengo Fukushima
    Kataoka, Noriyuki
    Oto, Takahiro
    Miyaji, Katsumasa
    Miura, Aya
    Ogawa, Aiko
    Yoshida, Masashi
    Ueda-Ishibashi, Hatsue
    Yutani, Chikao
    Ito, Hiroshi
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 165 (03) : 499 - 505
  • [36] DISTRIBUTION OF TRANSFORMING GROWTH-FACTOR-BETA-1, FIBRONECTIN, AND SMOOTH-MUSCLE ACTIN IN ASBESTOS-INDUCED PULMONARY FIBROSIS IN RATS
    PERDUE, TD
    BRODY, AR
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1994, 42 (08) : 1061 - 1070
  • [37] In Patients With Pulmonary Arterial Hypertension, Pulmonary Artery Smooth Muscle Cell Hypoxia Inducible Factor-1α Expression And Activity Is Decreased
    Barnes, E. A.
    Chen, C.
    Sedan, O.
    Cornfield, D. N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [38] Hypoxia-inducible factor-1 (HIF-1) does not mediate hypoxic inhibition of neonatal pulmonary artery smooth muscle cell proliferation
    Ambalavanan, N
    Bulger, A
    Philips, JB
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 23A - 23A
  • [39] Statins inhibit pulmonary artery smooth muscle cell proliferation by upregulation of HO-1 and p21WAF1
    Manxiang Li
    Yuan Liu
    Hongyang Shi
    Yonghong Zhang
    Guizuo Wang
    Jing Xu
    Jiamei Lu
    Dexin Zhang
    Xinming Xie
    Dong Han
    Yuanyuan Wu
    Shaojun Li
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2012, 385 : 961 - 968
  • [40] Statins inhibit pulmonary artery smooth muscle cell proliferation by upregulation of HO-1 and p21WAF1
    Li, Manxiang
    Liu, Yuan
    Shi, Hongyang
    Zhang, Yonghong
    Wang, Guizuo
    Xu, Jing
    Lu, Jiamei
    Zhang, Dexin
    Xie, Xinming
    Han, Dong
    Wu, Yuanyuan
    Li, Shaojun
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 (10) : 961 - 968